Does Insurance Cover TRT? Plans, Costs, and Denials

Health insurance does cover testosterone replacement therapy in many cases, but almost never automatically. Insurers treat TRT as a medically necessary treatment for specific diagnosed conditions, which means you generally need a confirmed diagnosis, lab work showing low testosterone, and often prior authorization before the plan will pay. The answer to “does insurance cover TRT” turns less on whether you have coverage and more on why you need the therapy, what formulation your doctor prescribes, and how well your records document the diagnosis.

When TRT Qualifies for Coverage

Across the major carriers, approval generally comes down to three categories of patients:

  • Primary or secondary hypogonadism. Conditions where the testicles, pituitary, or brain fail to produce adequate testosterone because of a congenital disorder (such as Klinefelter’s syndrome), surgery (bilateral orchiectomy), injury, or disease.
  • Delayed male puberty. Adolescents who have not entered puberty on a typical timeline may qualify, often with a requirement that a pediatric endocrinologist write the prescription.
  • Gender dysphoria. Transgender patients with a gender dysphoria diagnosis can qualify for testosterone as part of gender-affirming care, typically when prescribed by or in consultation with an endocrinologist or a clinician experienced in transgender medicine.

What insurance almost universally will not cover is testosterone prescribed for age-related decline alone. Late-onset hypogonadism, sometimes marketed as “Low T” in older men, is excluded by UnitedHealthcare, Aetna, Blue Cross Blue Shield, Cigna, and Medicare alike.{1UnitedHealthcare. Testosterone Replacement Supplementation Therapy} Performance enhancement is also explicitly excluded across all major plans.{2Cigna. Testosterone Injection and Implant Coverage Position Criteria}

What the Insurer Needs To See

Before approving coverage, insurers want objective proof that testosterone is genuinely low. The documentation standards are consistent across carriers, though the specific thresholds vary a bit.

Most plans require at least two separate morning blood draws showing total serum testosterone below a defined cutoff. UnitedHealthcare sets the threshold below 300 ng/dL, while Blue Cross Blue Shield of Michigan uses a slightly lower reference point of 264 ng/dL (harmonized to a CDC standard).{1UnitedHealthcare. Testosterone Replacement Supplementation Therapy}{3Blue Cross Blue Shield of Michigan. Medication Authorization Policy for Aveed and Testopel} Aetna and Cigna both require two confirmed low morning levels but defer to the testing laboratory’s normal range rather than naming a single number.{4Aetna. Clinical Policy Bulletin: Testosterone Cypionate Injections}{5Cigna. Testosterone Oral, Topical, and Nasal Coverage Position Criteria}

For patients with conditions that affect sex hormone-binding globulin, such as obesity, diabetes, HIV, or thyroid disorders, UnitedHealthcare allows an alternative: a single calculated free or bioavailable testosterone level below 50 pg/mL.{1UnitedHealthcare. Testosterone Replacement Supplementation Therapy} Kaiser Permanente takes a similar approach for patients with a BMI of 30 or above, requiring both total and free testosterone to fall below normal to confirm the hypogonadism diagnosis.{6Kaiser Permanente. Depo-Testosterone Formulary Criteria}

Beyond blood work, Blue Cross Blue Shield of Michigan asks for documentation of at least two clinical signs or symptoms of testosterone deficiency, which can range from specific indicators like small testes or incomplete sexual development to more general complaints like fatigue, depressed mood, or reduced libido.{3Blue Cross Blue Shield of Michigan. Medication Authorization Policy for Aveed and Testopel}

Which Formulations Get Covered

Insurance plans strongly favor generic injectable testosterone, specifically testosterone cypionate and testosterone enanthate. These are the workhorses of TRT coverage and are typically available without prior authorization. Blue Cross Blue Shield of Mississippi, for example, lists both as preferred formulary options with no prior authorization required, while every other delivery method on its formulary needs approval.{7Blue Cross Blue Shield of Mississippi. Testosterone Replacement Therapy Policy}

Topical gels and patches sit a tier below injectables at most carriers. Kaiser Permanente’s Northwest plan designates the 1.62% testosterone gel as its preferred topical, while Testim (1% gel) is non-formulary and requires a documented three-month trial failure of the preferred gel before it becomes eligible.{8Kaiser Permanente. Testim Formulary Criteria} Blue Cross Blue Shield of Mississippi requires patients to try injectable testosterone for a full three months before it will consider covering gels like AndroGel or Testim.{7Blue Cross Blue Shield of Mississippi. Testosterone Replacement Therapy Policy}

Oral testosterone formulations such as Jatenzo, Tlando, and Kyzatrex face significant coverage barriers. Blue Cross Blue Shield of Mississippi considers all oral testosterone products “not medically necessary.”{7Blue Cross Blue Shield of Mississippi. Testosterone Replacement Therapy Policy} Aetna and Western Health Advantage will cover them, but only after patients have tried and failed both generic injectables and generic topicals.{9Aetna. Testosterone Jatenzo, Kyzatrex, Tlando PA Policy}{10Western Health Advantage. Testosterone Oral Agents Prior Authorization}

Implantable testosterone pellets (Testopel) occupy a complicated spot. Aetna covers them for hypogonadism and gender dysphoria but considers them experimental for age-related decline.{11Aetna. Clinical Policy Bulletin: Implantable Hormone Pellets} Medicare’s position is that pellet use should be “rare” because the accepted standard of care is transdermal administration, and it caps coverage at six pellets per session with no allowance for wasted product.{12Noridian Medicare. Testopel Coverage}

Aveed, a long-acting testosterone undecanoate injection given every ten weeks, faces its own hurdles. Aetna requires patients to show that cheaper Depo-Testosterone was ineffective or caused intolerable side effects before it will cover Aveed.{13Aetna. Clinical Policy Bulletin: Aveed}

Compounded testosterone products, including custom-mixed creams, gels, and pellets prepared by compounding pharmacies, are almost universally excluded. Insurers cite the lack of FDA approval and the availability of FDA-approved alternatives in multiple dosage forms.{14Cigna. Compounded Medications Coverage Position Criteria}

Prior Authorization and Step Therapy

Even with a qualifying diagnosis and the right lab results, most non-injectable formulations require prior authorization. In that process, your prescriber submits clinical documentation to the insurer to justify the treatment before the pharmacy can fill it.

Step therapy adds another layer. That is the rule that patients try cheaper medications first before the plan will cover a pricier option. In practice, you’ll likely need to try generic testosterone cypionate injections before an insurer approves a gel, and a gel before it approves an oral product. Blue Cross Blue Shield of Michigan, for instance, requires documented trial and failure of either generic Depo-Testosterone or generic Delatestryl before it will authorize Aveed or Testopel.{3Blue Cross Blue Shield of Michigan. Medication Authorization Policy for Aveed and Testopel} A “trial” is typically defined as three months of treatment at an appropriate dose.{7Blue Cross Blue Shield of Mississippi. Testosterone Replacement Therapy Policy}

Roughly 14% to 30% of TRT prior authorization requests are initially denied. Of those, about 40% to 60% are approved on the first appeal when complete medical records are submitted. Peer-to-peer reviews, where the prescribing doctor speaks directly with the insurer’s medical director, resolve an additional 20% to 40% of denials before a formal appeal is even filed.{15HealthRX. TRT Prior Authorization}

Coverage by Plan Type

Employer and Individual Commercial Plans

Coverage under employer-sponsored and individual commercial plans is governed by each plan’s specific benefit document. There is no federal rule that these plans cover TRT in particular, but prescription drug coverage is an essential health benefit under the ACA, and most state benchmark plans include at least some testosterone formulations.{16CMS. Essential Health Benefits} The practical result: most commercial plans cover generic injectable testosterone for documented hypogonadism, with stricter prior authorization gates for brand-name and non-injectable formulations.

Medicare

Medicare has no national coverage determination for TRT, so coverage decisions fall to regional contractors and individual plan rules. Part B covers testosterone administered by a healthcare professional in an outpatient setting, with Medicare paying 80% after the Part B deductible and the patient responsible for 20% coinsurance.{} Part D covers self-administered formulations such as gels, patches, and at-home injections, subject to each plan’s formulary. For 2025, the Part D deductible is $590, beneficiaries pay 25% of drug costs up to a $2,000 out-of-pocket maximum, and there are no further out-of-pocket costs after that cap.{17Medical News Today. Does Medicare Cover TRT}

Medicare’s local coverage determination requires at least two fasting serum testosterone levels drawn before 10 AM on separate days, along with follow-up LH and FSH testing, PSA screening, digital prostate exams, and hematocrit monitoring.{} Patients with current breast or prostate cancer, a hematocrit above 48%, a PSA above 4 ng/mL, or a recent cardiovascular event within the past six months are excluded from coverage.{18CMS. Local Coverage Determination L39086}

Medicaid

Medicaid coverage varies by state because each state runs its own program with its own preferred drug list and prior authorization rules. Ohio’s Medicaid program covers testosterone cypionate, testosterone enanthate, Testopel, and Aveed through UnitedHealthcare’s community plan.{19UnitedHealthcare. Testosterone Replacement Supplementation Therapy Ohio Community Plan} Some states impose additional hurdles: Massachusetts, for example, requires six months of documented low testosterone before approval. TRT for transgender individuals is covered through Medicaid in most states, though a handful, including Idaho, Indiana, Nebraska, North Carolina, South Carolina, and Wisconsin, do not cover it for gender-affirming care.{20PRCPB. Does Medicaid Cover Testosterone Replacement Therapy}

TRICARE and VA

TRICARE covers hormone replacement therapy through its pharmacy benefit when the medication is FDA-approved and prescribed for its labeled indications.{21TRICARE. Hormone Replacement Therapy} The VA includes topical testosterone gel on its national formulary, though local prior authorization is required, and the VA prioritizes generic products.{22VA. Testosterone Gel Formulary Advisor}

What You’ll Pay With Insurance

With insurance coverage and a confirmed hypogonadism diagnosis, copays for generic testosterone injections typically run $15 to $50 per month. Brand-name gels or patches carry higher copays, often $75 to $150 or more monthly. Specialist visits generally cost $30 to $80, and lab work may be covered as diagnostic care, though patients on high-deductible plans could owe the full negotiated rate until they hit their deductible.{23PolicyLab. Testosterone Replacement Therapy Cost} GoodRx data shows that 77% of insurance plans cover generic Depo-Testosterone with a copay of $60 to $80, though discount coupons can sometimes beat the insurance price.{24GoodRx. Depo-Testosterone Prices and Coupons}

What You’ll Pay Without Insurance

Paying entirely out of pocket, costs vary dramatically by formulation:

Budget as well for monitoring, including blood tests, provider visits, and dose adjustments, which can add roughly $300 per year.{25Hims. How Much Does Testosterone Cost}

Online TRT Clinics Usually Don’t Take Insurance

The growing market of telehealth TRT providers operates almost entirely on cash. Clinics like Male Excel, Peter MD, Hone Health, Fountain TRT, and Defy Medical do not accept insurance for their services.{} Pricing structures vary, and advertised monthly rates rarely reflect total costs: entry fees, lab processing charges, and medication can add $50 to $200 per month beyond the base subscription.{} Some clinics, like Fountain TRT, will provide a bill on request so patients can try for reimbursement from their insurer, but this is the exception.{26PolicyLab. Online TRT Providers}

Ways To Lower the Cost

Several strategies can bring the price down whether or not insurance is involved:

  • Prescription discount programs. GoodRx coupons can reduce the retail price of generic testosterone cypionate to as low as $22 for a one-month supply, which is often cheaper than an insurance copay.{}24GoodRx. Depo-Testosterone Prices and Coupons
  • 90-day fills. Filling a 90-day supply instead of monthly can reduce total costs, though it requires a prescription written for the larger quantity.{}27GoodRx. Testosterone Prices and Coupons
  • Mail-order pharmacies. Insured patients may get lower rates through their plan’s preferred mail-order pharmacy, and some plans require mail order for supplies beyond 30 days.{}27GoodRx. Testosterone Prices and Coupons
  • HSA and FSA accounts. TRT is an eligible expense for Health Savings Accounts, Flexible Spending Accounts, and Health Reimbursement Arrangements with a prescription, including at cash-pay clinics.{}{} Treatments used solely for cosmetic purposes do not qualify.28FSAFEDS. HCFSA Eligible Expenses29FSA Store. Progesterone and Testosterone Hormones FSA Eligibility
  • Manufacturer copay programs. Brands like Tlando and Jatenzo offer copay assistance cards that can significantly reduce out-of-pocket costs for commercially insured patients.{}30National Library of Medicine. Oral Testosterone Undecanoate Formulations

If Your Coverage Is Denied

A denial is not the final word. The appeals process has two stages: an internal appeal handled by the insurance company, followed by an external review conducted by an independent third party if the internal appeal fails.{31NAIC. Health Insurance Claim Denied: How To Appeal a Denial}

Insurers must decide internal appeals within 72 hours for urgent claims, 30 days for treatments not yet received, and 60 days for services already provided.{31NAIC. Health Insurance Claim Denied: How To Appeal a Denial} To build the strongest case, work with your prescribing doctor to submit a letter of medical necessity that addresses the insurer’s specific reason for denial, includes lab results and medical history, references clinical guidelines, and explains the health consequences of going without treatment.{32Patient Advocate Foundation. Tips for Appealing Insurance Denials}

First, though, check whether the denial resulted from an administrative error like a misspelled name, wrong date, or incorrect ID number, since a simple resubmission can resolve those.{32Patient Advocate Foundation. Tips for Appealing Insurance Denials} Independent external reviewers overturn roughly 39% to 59% of well-documented denied claims, so persistence pays.{15HealthRX. TRT Prior Authorization}

A Note on TRT for Women

There are no FDA-approved testosterone products for women in the United States. The FDA declined to approve a transdermal testosterone patch for women in 2004, citing insufficient long-term safety data.{33VA. Testosterone HSDD Clinical Summary} Because every use of testosterone in women is technically off-label, insurance coverage is rare, and compounded testosterone, the most common form prescribed for women, is almost never covered.{} Office visits and lab monitoring may still be covered. Compounded testosterone for women typically costs $45 to $90 per month out of pocket.{34HealthyWomen. Testosterone for Women}